PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 2042571
PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 2042571
Catheter Stabilization Device Market size was valued at US$ 1,071.82 Million in 2025, expanding at a CAGR of 8.43% from 2026 to 2033.
Catheter stabilization refers to methods or devices used to securely hold a catheter in place on a patient's body. It helps reduce unwanted movement, discomfort, and accidental dislodgement during medical care. Keeping the catheter steady, it supports safer treatment, lowers irritation at the insertion site, and assists healthcare staff in maintaining hygiene and consistent device function. The catheter stabilization market involves products designed to secure medical tubes used in treatment. It reflects steady healthcare demand globally.
The catheter stabilization market is shaped by the growing use of intravenous therapies, surgeries, and long-term care practices across hospitals and home settings. Health organizations, including World Health Organization and the Centers for Disease Control and Prevention, advocate infection control and appropriate device handling as key components of patient care. For instance, CDC guidelines on catheter-associated infections emphasize securing strategies to avoid adverse effects. Similarly, the WHO patient safety campaign calls for appropriate device handling in clinical settings. Furthermore, the development of healthcare facilities in nations such as India and China has facilitated the continued use of stabilization procedures within medical practice.
Catheter Stabilization Device Market- Market Dynamics
Advancements in device design and clinical guidelines to encourage usage
Ongoing advancements in catheter stabilization solutions are supporting broader adoption in clinical practice. Today's devices are constructed using state-of-the-art adhesives, skin-friendly products, and built-in dressings, which minimize pain while providing stability. Research in clinical settings shows that today's device securement solutions significantly decrease catheter displacement and enhance their effectiveness over older techniques such as tape and sutures.
Concurrently, industry professional standards and guidelines underscore the need for the incorporation of stabilization as one of the key elements of safe catheter access techniques. There is an increasing effort among companies and healthcare facilities to promote such practices and ensure their implementation through training. Companies like Teleflex Incorporated still work on improving their products and educating clinicians about the best ways to use them.
The Global Catheter Stabilization Device Market is segmented on the basis of Product, Application, End User, and Region.
Under product categories, the market is divided into five types. Among these, CVC (central venous catheter) securement devices hold a significant position due to their close link with critical care and infection prevention practices. Central lines are widely used for long-term therapies such as medication delivery, nutrition, and intensive care support. However, they carry a higher risk of bloodstream infections if not properly managed. The CDC states that central line-associated infections may result in severe complications, which necessitate the adoption of stringent procedures, such as the utilization of securement devices to minimize movement. Medical technology companies such as 3M Company and ConvaTec Group plc have developed advanced securement solutions designed for central lines, focusing on stability, skin protection, and ease of monitoring. Such tools enable clinical recommendations on sutureless securement to be followed for increasing safety and minimizing infection risks. The need for such devices will likely persist due to the growing importance of vascular access as well as prolonged treatment procedures in hospitals.
In terms of application, oncology procedures maintain a strong position in the catheter stabilization device market due to the repeated and long-term use of vascular access in cancer care. Cancer treatments such as chemotherapy, immunotherapy, and supportive infusions require reliable and continuous access to veins, often through central lines or PICC lines. Clinical sources note that central venous catheters are routinely used in oncology to deliver medications, fluids, and nutrition over extended periods, reducing damage to peripheral veins and improving treatment continuity. Since these types of catheters stay inside the body for extended periods, it is vital to stabilize them to avoid displacement and infections. The literature on medical practices shows that these catheters are often used in oncology and pose dangers such as infections and blood clots, making it necessary to have proper methods of stabilization. Firms such as B. Braun SE and ConvaTec Group plc manufacture products aimed at stabilizing these types of catheters. This information proves that oncology procedures continue to be relevant in defining the market for catheter stabilization products.
Catheter Stabilization Device Market- Geographical Insights
Across global healthcare markets, the catheter stabilization device market is influenced by clinical practices, infection prevention priorities, and the structure of healthcare systems across regions. North America is expected to register meaningful growth due to its structured healthcare policies and strong emphasis on patient safety. A number of agencies have endorsed the use of sutureless securement devices for minimizing the risk of infections during the placement of catheters. Furthermore, statistics provided by the Agency for Healthcare Research and Quality reveal that there is a considerable burden of infections acquired within hospitals, thereby necessitating the adoption of more effective stabilization methods. Firms like 3M Company and Cardinal Health are consistently providing assistance in this regard.
At the same time, Asia-Pacific is also set to maintain prominence in the market, supported by expanding healthcare access and rising awareness of infection prevention. Guidance from the World Health Organization highlights that a large share of hospitalized patients require catheter use during treatment, increasing the importance of safe handling and stabilization practices. Countries such as India and China are investing in hospital infrastructure and training programs aligned with WHO recommendations on catheter-related infection control. Regional manufacturing and distribution efforts by companies like B. Braun SE further support availability. These developments indicate a steady shift toward safer and more consistent catheter management practices across emerging healthcare systems.
Canada Catheter Stabilization Device Market- Country Insights
Canada's catheter stabilization device market reflects a healthcare system that places strong attention on infection control and safe clinical practices. Public Health Agency of Canada reports have found that device-associated infections, such as central line-associated bloodstream infections, are still among the monitored problems within hospitals, with many thousands of patients affected in the national surveillance programs. At the same time, catheter usage in intensive care units remains consistently high, showing the continued reliance on vascular access in treatment. This encourages healthcare providers to adopt stabilization solutions that help reduce movement and contamination risks. Canadian innovation efforts are also visible, as initiatives supported by the CAN Health Network have enabled hospitals like Hamilton Health Sciences to adopt advanced catheter care technologies, including solutions from SterileCare Inc., which demonstrated reduced infection outcomes in clinical settings. These combined public health efforts and industry participation support steady adoption of catheter stabilization practices across the country.
The catheter stabilization device market reflects a balanced mix of global manufacturers and regional suppliers, creating a diverse and adaptive business environment. Examples of companies that utilize hospital distribution include 3M Company, B. Braun SE, and ConvaTec Group plc. Their main concerns are the efficiency of the products, ease of use, patient comfort, and infection control. Continuous improvements in adhesive materials and securement designs support wider acceptance across healthcare facilities and home care settings.
The players in the industry have also been following gradual growth strategies that will make them stronger and more accessible. Strategies such as collaborations, local production, and improvements in the supply chain are quite common. In March 2025, for example, Teleflex Incorporated made improvements to its vascular access product line, which includes securement devices. Companies continue to invest in training programs and product awareness initiatives, helping healthcare professionals adopt safer catheter management practices. These developments contribute to steady progress in clinical care standards and product availability.
In February 2026, ICU Medical Inc. expanded its product development focus on advanced IV therapy and catheter stabilization systems, supporting safer infusion practices and aligning with evolving clinical requirements in hospitals. ICU Medical's expansion supports safer infusion care, strengthens catheter stabilization innovation, and aligns product development with evolving hospital treatment needs globally.
In January 2026, Becton Dickinson and Company announced continued investment in vascular access solutions, including catheter securement technologies, to improve patient safety and reduce complications in hospital care settings, as highlighted in its corporate updates and healthcare innovation programs. Becton Dickinson's investment strengthens vascular access care, enhances catheter securement practices, and supports safer patient outcomes across evolving hospital treatment environments.